Ms. Anne Wojcicki is a Co-Founder and serves as Chief Executive Officer & Board Member at 23andMe. Prior to founding the firm in 2006, she had a 10-year background in healthcare investing, focused primarily on biotechnology companies. She is also a General Partner at Covalence Life Sciences Partners. Prior to joining Covalence she served as a Senior Research Analyst for healthcare of Amerindo Investment Advisors. Prior to that, Ms. Wojcicki was at Andor Capital Management as Healthcare Analyst, Ardsley Partners as Healthcare Analyst and Investor AB as Senior Healthcare Analyst. Ms. Wojcicki also worked at the National Institute of Health as a Research Associate in Oncology and Hematology. She also worked at the Weizmann Institute as a Research Associate in Biochemistry and at Yale University as a Research Associate in the Biochemistry Department. Ms. Wojcicki holds a B.S. in Biology from Yale University in 1996.